Tom C Thomas insider trades: Vincerx Pharma (VINC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tom reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | VINC | ↑ Buy | 5,000 | $0.95 | $5K | Direct | Aug 10, 2023 (0d) |
| Dec 14, 2022 | VINC | ↑ Buy | 7,000 | $0.83 | $6K | The Thomas Family Revocable Trust, dated | Dec 14, 2022 (0d) |
| Dec 22, 2021 | VINC | ↑ Buy | 1,000 | $10.23 | $10K | The Thomas Family Revocable Trust, dated | Dec 27, 2021 (5d) |
| Jun 29, 2021 | VINC | ↑ Buy | 2,000 | $12.58 | $25K | The Thomas Family Revocable Trust, dated | Jun 30, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Tom C Thomas's insider trades
Tom C Thomas is See Remarks at Vincerx Pharma (VINC). Since Jun 29, 2021, Tom has reported 4 open-market purchases worth $46K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), option exercises (6 filings), shares withheld for taxes (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VINC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.